Accretion Pharmaceuticals
add_icon

Accretion Pharmaceuticals

63.55
-0.75
(-1.17%)
Market Cap
70.64 Cr
PE Ratio
10.52
Volume
4,800.00
Day High - Low
64.90 - 63.55
52W High-Low
102.50 - 53.80
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
70.64 Cr
EPS
8.48
PE Ratio
10.52
PB Ratio
1.59
Book Value
40.52
EBITDA
12.00
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
44.44
Debt to Equity
1.33
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,783.20
#1 4,27,849.41
39.44
#1 54,729.00
9.71
#1 10,980
16.07
56.64
6,071.00
1,61,165.97
64.98
9,712.00
18.67
2,191
-1.02
38.37
4,266.60
1,44,401.13
65.37
11,539.40
6.99
1,911
26.24
49.65
1,276.90
1,06,573.95
19.54
33,741.20
16.73
5,725
-15.28
47.81
1,300.00
1,05,010.33
23.42
28,409.50
7.12
5,291
-57.18
36.50
2,290.40
1,04,625.20
22.66
22,909.50
13.74
3,306
#1 37.44
53.17
886.90
89,242.89
#1 18.14
23,511.00
18.55
4,615
-0.32
42.14
2,094.70
86,470.28
48.94
12,744.20
#1 20.90
2,007
7.65
43.63
1,279.60
74,319.38
21.60
32,345.60
9.43
3,484
7.59
61.70
5,323.00
63,644.45
26.41
13,458.30
3.70
2,216
1.90
39.37

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
329.10 %
Net Income Growth
353.33 %
Cash Flow Change
149.96 %
ROE
63.50 %
ROCE
248.60 %
EBITDA Margin (Avg.)
6.76 %

Yearly Financial Results

Annual Financials
2024
2025
TTM
Revenue
13
58
0
Expenses
11
46
0
EBITDA
3
12
0
Operating Profit %
19 %
21 %
0 %
Depreciation
0
1
0
Interest
0
1
0
Profit Before Tax
2
10
0
Tax
1
3
0
Net Profit
2
7
0
EPS in ₹
1.96
8.48
0.00

Balance Sheet

Balance Sheet
2024
2025
Total Assets
27
40
Fixed Assets
5
6
Current Assets
22
34
Capital Work in Progress
0
0
Investments
0
0
Other Assets
22
34
Total Equity & Liabilities
27
40
Current Liabilities
15
23
Non Current Liabilities
7
1
Total Equity
6
15
Reserve & Surplus
2
7
Share Capital
4
8

Cash Flow

Cash Flow
2024
2025
Net Cash Flow
0
0
Investing Activities
-6
-2
Operating Activities
-12
6
Financing Activities
17
-4

Share Holding

% Holding
Sept 2024
Jan 2025
May 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
100.00 %
100.00 %
73.50 %
73.50 %
73.52 %
73.52 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
19.44 %
21.46 %
22.85 %
22.01 %
Others
0.00 %
0.00 %
7.06 %
5.04 %
3.63 %
4.47 %
No of Share Holders
8
8
8
1,628
1,498
1,179

Technical Indicators

RSI(14)
Neutral
40.68
ATR(14)
Less Volatile
2.63
STOCH(9,6)
Neutral
44.53
STOCH RSI(14)
Neutral
42.52
MACD(12,26)
Bullish
0.00
ADX(14)
Strong Trend
29.50
UO(9)
Bearish
50.78
ROC(12)
Downtrend And Accelerating
-6.06
WillR(14)
Oversold
-83.75